Longitudinal changes in regional fat and muscle composition and cardiometabolic biomarkers over 5 years of hormone therapy in transgender individuals

Documenti analoghi

• The combination of statin and ezetimibe is safe, effective, and preferable
  di: Mats Eriksson
  Pubblicazione: (2025)
• Gender‐affirming hormone therapy for transgender and gender‐diverse adults in Australia
  di: Brendan J. Nolan, et al.
  Pubblicazione: (2024)
• Colonoscopy findings after increasing two‐stool faecal immunochemical test (FIT) cut‐off: Cross‐sectional analysis of the SCREESCO randomized trial
  di: Marcus Westerberg, et al.
  Pubblicazione: (2024)
• Metabolomics in cardiometabolic diseases: Key biomarkers and therapeutic implications for insulin resistance and diabetes
  di: David Rizo‐Roca, et al.
  Pubblicazione: (2025)
• Emerging methods for subtype differentiation in primary aldosteronism
  di: Oskar Ragnarsson, et al.
  Pubblicazione: (2025)